Top Markets
Coin of the day
TherapeuticsMD, Inc. TherapeuticsMD, Inc.

TherapeuticsMD, Inc.

TXMD
株式のランク #28984
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to... TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception. In its developmental pipeline, TherapeuticsMD is advancing several preclinical candidates: TX-005HR, a transdermal cream containing only progesterone; TX-006HR, another transdermal cream formulated with both estradiol and progesterone; TX-007HR and TX-008HR, both experimental transdermal patches; and TX-009HR, an oral formulation of progesterone and estradiol. Beyond its core pharmaceutical offerings, the company produces and distributes both branded and generic prescription prenatal vitamins, notably under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 labels. Its prescription medications and prenatal vitamin lines reach consumers through established channels, including wholesale and retail pharmacy distributors. Established in 2008, TherapeuticsMD, Inc. maintains its corporate headquarters in Boca Raton, Florida.
株価
$2.04
時価総額
$23.61M
変化(1日)
1.49%
変化(1年)
75.86%
US
取引 TherapeuticsMD, Inc. (TXMD)

カテゴリー

TherapeuticsMD, Inc.(TXMD)の株価履歴
終値の最高値: $2.06 (2026-08-01)

終値の最安値: $4.17K (2007-05-01)
TherapeuticsMD, Inc. の株価履歴(2007 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 9.61%
2025 42.24%
2024 -49.81%
2023 -60.69%
2022 -71.44%
2021 -65.86%
2020 -48.98%
2019 -41.07%
2018 -34.14%
2017 3.27%
2016 -34.14%
2015 126.22%
2014 -15.87%
2013 64.19%
2012 98.37%
2011 -65.70%
2010 -97.08%
2009 192.45%
2008 18.20%
2007 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$164.10 26.95%
DE
$37.64 23.14%
JP
$222.33 32.79%
CH
$20.97 12.27%
IN